2023-25946. Bulk Manufacturer of Controlled Substances Application: Organix Chemistry Solutions, LLC  

  • Start Preamble

    AGENCY:

    Drug Enforcement Administration, Justice.

    ACTION:

    Notice of application.

    SUMMARY:

    Organix Chemistry Solutions, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

    DATES:

    Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before January 23, 2024. Such persons may also file a written request for a hearing on the application on or before January 23, 2024.

    ADDRESSES:

    The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment.

    End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In accordance with 21 CFR 1301.33(a), this is notice that on September 29, 2023, Organix Chemistry Solutions LLC, 240 Salem Street, Woburn, Massachusetts 01801–2029, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s):

    Controlled substanceDrug codeSchedule
    Gamma Hydroxybutyric Acid2010I
    Lysergic acid diethylamide7315I
    Marihuana7360I
    Tetrahydrocannabinols7370I
    Mescaline7381I
    3,4,5-Trimethoxyamphetamine7390I
    4-Bromo-2,5-dimethoxyphenethylamine7392I
    3,4-Methylenedioxyamphetamine7400I
    3,4-Methylenedioxymethamphetamine7405I
    5-Methoxy-N-N-dimethyltryptamine7431I
    Alpha-Methyltryptamine7432I
    Bufotenine7433I
    Diethyltryptamine7434I
    Dimethyltryptamine7435I
    Psilocybin7437I
    Psilocyn7438I
    2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C–D)7508I
    2-(2,5-Dimethoxyphenyl) ethanamine (2C–H)7517I
    2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine (2C–I)7518I
    Heroin9200I
    Morphine9300II
    Start Printed Page 82399

    The company plans to synthesize the listed controlled substances for distribution to its customers. In reference to drug codes 7360 (Marihuana), and 7370 (Tetrahydrocannabinols), the company plans to bulk manufacture these drugs as synthetic. No other activities for these drug codes are authorized for this registration.

    Start Signature

    Claude Redd,

    Acting Deputy Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2023–25946 Filed 11–22–23; 8:45 am]

    BILLING CODE P

Document Information

Published:
11/24/2023
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice of application.
Document Number:
2023-25946
Dates:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before January 23, 2024. Such persons may also file a written request for a hearing on the application on or before January 23, 2024.
Pages:
82398-82399 (2 pages)
Docket Numbers:
Docket No. DEA-1288
PDF File:
2023-25946.pdf